{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:05:12Z","timestamp":1737435912904,"version":"3.33.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1136\/ard.2004.030338","type":"journal-article","created":{"date-parts":[[2005,7,13]],"date-time":"2005-07-13T21:12:39Z","timestamp":1121289159000},"page":"1165-1173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Up regulated expression of tumour necrosis factor \u03b1 converting enzyme in peripheral monocytes of patients with early systemic sclerosis"],"prefix":"10.1016","volume":"64","author":[{"given":"T","family":"Bohgaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Amasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bohgaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K-i","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Jodo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2004.030338_bib1","first-page":"1455","article-title":"Systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds","author":"Wigley","year":"2003","journal-title":"Rheumatology"},{"issue":"Suppl 48","key":"10.1136\/ard.2004.030338_bib2","first-page":"53","article-title":"Hypothesis for the pathogenesis of systemic sclerosis","volume":"24","author":"Furst","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030338_bib3","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.20315","article-title":"Is systemic sclerosis an antigen-driven T cell disease?","volume":"50","author":"Sakkas","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib4","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.030338_bib5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI0215078","article-title":"CD19-dependent B lymphocyte signalling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse","volume":"109","author":"Saito","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2004.030338_bib6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/art.10413","article-title":"Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis","volume":"46","author":"Varga","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib7","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.4049\/jimmunol.167.12.7126","article-title":"Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts","volume":"167","author":"Zhou","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.030338_bib8","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.11080","article-title":"Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+T cells from scleroderma patients","volume":"48","author":"Luzina","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.bmt.1703868","article-title":"The promise of haematopoietic stem cell transplantation for autoimmune diseases","volume":"31","author":"Burt","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1136\/ard.2004.030338_bib10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/ard.60.7.702","article-title":"Haematopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000","volume":"60","author":"Tyndall","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.030338_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.60.6.577","article-title":"Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease","volume":"60","author":"Binks","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.030338_bib12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2169\/internalmedicine.41.608","article-title":"High-dose immunoablative therapy with haematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction","volume":"41","author":"Tyndall","year":"2002","journal-title":"Intern Med"},{"key":"10.1136\/ard.2004.030338_bib13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2003.011205","article-title":"Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT\/EULAR registry","volume":"63","author":"Farge","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.030338_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"ARA","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib15","first-page":"202","article-title":"Scleroderma (systemic sclerosis); classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030338_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib17","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib18","first-page":"1520","article-title":"High resolution computed tomography in early scleroderma lung disease","volume":"18","author":"Warrick","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030338_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7326\/0003-4819-94-1-38","article-title":"The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis","volume":"94","author":"Roberts","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2004.030338_bib23","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1074\/jbc.M211143200","article-title":"Up-regulated Smad5 mediates apoptosis of gastric epithelial cells induced by Helicobactor pylori infection","volume":"278","author":"Nagasako","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2004.030338_bib24","doi-asserted-by":"crossref","first-page":"32801","DOI":"10.1074\/jbc.M209993200","article-title":"Membrane-anchored CD40 is processed by the tumour necrosis factor-\u03b1-converting enzyme","volume":"278","author":"Contin","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2004.030338_bib25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00002281-200311000-00015","article-title":"The role of chemokines in the pathogenesis of scleroderma","volume":"15","author":"Atamas","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.2004.030338_bib26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1073\/pnas.79.4.1286","article-title":"Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors","volume":"79","author":"LeRoy","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2004.030338_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J Pathol"},{"key":"10.1136\/ard.2004.030338_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000163933","article-title":"Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes\/macrophages","volume":"63","author":"Kr\u00e4ling","year":"1995","journal-title":"Pathobiology"},{"key":"10.1136\/ard.2004.030338_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1568-9972(03)00004-1","article-title":"New insights into the pathogenesis of systemic sclerosis","volume":"2","author":"Tamby","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2004.030338_bib30","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/1529-0131(200106)44:6<1382::AID-ART231>3.0.CO;2-T","article-title":"Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression","volume":"44","author":"Galindo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s004030000134","article-title":"Chemokine release from activated human dermal microvascular endothelial cells\u2014implications for the pathophysiology of scleroderma?","volume":"292","author":"Anderegg","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.1136\/ard.2004.030338_bib33","first-page":"99","article-title":"Molecular cloning of the MCP-3 chemokine gene and regulation of its expression","volume":"4","author":"Minty","year":"1993","journal-title":"Eur Cytokine Netw"},{"key":"10.1136\/ard.2004.030338_bib34","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/art.11164","article-title":"Monocyte chemoattractant protein 3 as a mediator of fibrosis. Over expression in systemic sclerosis and type 1 tight-skin mouse","volume":"48","author":"Ong","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1600-0625.2002.110205.x","article-title":"Expression of the C-C chemokine MIP-3\u03b1\/CCL20 in human epidermis with impaired permeability barrier function","volume":"11","author":"Schmuth","year":"2002","journal-title":"Exp Dermatol"},{"key":"10.1136\/ard.2004.030338_bib36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-\u03b1 from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"10.1136\/ard.2004.030338_bib37","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/385733a0","article-title":"Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-\u03b1","volume":"385","author":"Moss","year":"1997","journal-title":"Nature"},{"key":"10.1136\/ard.2004.030338_bib38","first-page":"1756","article-title":"Tumour necrosis factor-\u03b1 (TNF-\u03b1) converting enzyme contributes to production of TNF-\u03b1 in synovial tissues from patients with rheumatoid arthritis","volume":"28","author":"Ohta","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030338_bib39","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.4049\/jimmunol.160.9.4570","article-title":"TNF-\u03b1 convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-\u03b1","volume":"160","author":"Patel","year":"1998","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.030338_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1191\/1352458502ms830oa","article-title":"TACE mRNA expression in peripheral mononuclear cells precedes new lesions on MRI in multiple sclerosis","volume":"8","author":"Seifert","year":"2002","journal-title":"Mult Scler"},{"key":"10.1136\/ard.2004.030338_bib41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.18388\/abp.2003_3656","article-title":"Structure and functions of tumour necrosis factor-\u03b1 converting enzyme","volume":"50","author":"Mezyk","year":"2003","journal-title":"Acta Biochim Pol"},{"key":"10.1136\/ard.2004.030338_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1043-4666(03)00117-0","article-title":"In situ localization of TNF-\u03b1\/\u03b2, TACE and TNF-receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue","volume":"22","author":"Ermert","year":"2003","journal-title":"Cytokine"},{"key":"10.1136\/ard.2004.030338_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO;2-4","article-title":"IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages","volume":"28","author":"Allavena","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2004.030338_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-1119(99)00155-9","article-title":"cDNA cloning of mouse tumour necrosis factor-\u03b1 converting enzyme (TACE) and partial analysis of its promoter","volume":"233","author":"Mizui","year":"1999","journal-title":"Gene"},{"key":"10.1136\/ard.2004.030338_bib45","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1074\/jbc.M010149200","article-title":"CTGF and SMADS, maintenance of scleroderma phenotype is independent of SMAD signalling","volume":"276","author":"Holmes","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2004.030338_bib46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/art.1780400321","article-title":"Up-regulation of class II major histocompatibility complex and intracellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-\u03b3 and tumour necrosis factor \u03b1 in the early disease stage","volume":"40","author":"Gruschwitz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib47","first-page":"1936","article-title":"In situ expression and serum levels of tumour necrosis factor-\u03b1 receptors in patients with early stage of systemic sclerosis","volume":"24","author":"Gruschwitz","year":"1997","journal-title":"J Rheumatol"},{"issue":"Suppl 9","key":"10.1136\/ard.2004.030338_bib48","first-page":"S392","article-title":"Etanercept as treatment for diffuse scleroderma: a pilot study [abstract]","volume":"43","author":"Ellman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumour necrosis factor is the prime activating ligand of the 80 kDa tumour necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"key":"10.1136\/ard.2004.030338_bib50","doi-asserted-by":"crossref","first-page":"18542","DOI":"10.1016\/S0021-9258(17)46661-0","article-title":"Ligand passing: the 75-kDa tumour necrosis factor (TNF-) receptor recruits TNF- for signalling by the 55-kDa TNF-receptor","volume":"268","author":"Tartaglia","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2004.030338_bib51","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.95.2.570","article-title":"The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumour necrosis factor","volume":"95","author":"Grell","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2004.030338_bib52","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/385540a0","article-title":"MAP3K-related kinase involved in NF-\u03baB induction by TNF, CD95 and IL-1","volume":"385","author":"Malinin","year":"1997","journal-title":"Nature"},{"key":"10.1136\/ard.2004.030338_bib53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S1074-7613(00)80152-1","article-title":"Regulated commitment of TNF-receptor signalling: a molecular switch for death or activation","volume":"11","author":"Pimentel-Muinos","year":"1999","journal-title":"Immunity"},{"key":"10.1136\/ard.2004.030338_bib54","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.282.5392.1281","article-title":"An essential role for ectodomain shedding in mammalian development","volume":"282","author":"Peschon","year":"1998","journal-title":"Science"},{"key":"10.1136\/ard.2004.030338_bib55","doi-asserted-by":"crossref","first-page":"15220","DOI":"10.1074\/jbc.275.20.15220","article-title":"Tumour necrosis factor \u03b1 suppresses the induction of connective tissue growth factor by transforming growth factor-\u03b2 in normal and scleroderma fibroblasts","volume":"275","author":"Abraham","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2004.030338_bib56","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.4049\/jimmunol.171.7.3855","article-title":"Antagonistic effects of TNF-\u03b1 on TGF-\u03b2 signalling through down-regulation of TGF-\u03b2 receptor type II in human dermal fibroblasts","volume":"171","author":"Yamane","year":"2003","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.030338_bib57","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0022-3565(24)29455-6","article-title":"Inhibition of tumour necrosis factor-\u03b1 (TNF-\u03b1) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-\u03b1-converting enzyme and matrix metalloproteinases","volume":"298","author":"Conway","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1136\/ard.2004.030338_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/art.1780210111","article-title":"Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations","volume":"21","author":"Clements","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030338_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/ard.60.6.585","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres","volume":"60","author":"Della","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.030338_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0889-857X(05)70305-7","article-title":"Scleroderma renal crisis","volume":"22","author":"Steen","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.2004.030338_bib31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/art.1780400422","article-title":"Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis","volume":"40","author":"Bolster","year":"1997","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724428963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724428963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.030338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:54:22Z","timestamp":1737359662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724428963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0003496724428963"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.030338","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Up regulated expression of tumour necrosis factor \u03b1 converting enzyme in peripheral monocytes of patients with early systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.030338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}